Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

MoonLakes steep decline is being debated amid uncertainty over the FDAs review of its sonelokimab application for hidradenitis suppurativa and how the company would commercialize the drug. Some investors see clinical potential and a buying opportunity, while skeptics point to regulatory and competitive risks, management concerns, and possible future dilution if MoonLake goes it alone.

The tokens prolonged slide and allegations that insiders profited while retail holders absorbed losses dominate discussion, with many calling it a scam or questioning its lasting value. A smaller bullish contingent expects a speculative rebound or short squeeze, but no specific verified catalyst is evident.

AVT is drawing attention amid a volatile rebound and heavy trading in a thinly traded token, with traders speculating about a breakout or squeeze. Aventus Clouds decentralized-compute updates add a bullish project narrative, while concerns about concentrated holdings, selling pressure, and the prior exploit-driven selloff temper enthusiasm.

Devons agreed sale of its Eagle Ford assets to Crescent Energy is drawing attention as a portfolio-streamlining move and completes a process that had previously fueled takeover speculation. Traders are split between viewing the deal as value-unlocking and questioning why the shares have not responded more strongly.

Amkors sharp selloff despite a strong quarterly report is being attributed to softer-than-expected revenue guidance and broader semiconductor weakness. Traders are split between viewing the decline as an overreaction and buying the dip on the companys AI advanced-packaging role, and worrying about near-term demand, spending, and continued sector pressure.

SK Hynix is caught in a sharp memory-chip selloff as reports of Chinese rival CXMTs progress in denser DRAM stoke fears of future competition, alongside broader pressure on AI and semiconductor stocks and weakness in Korean markets. Traders are divided: bears see risks to the memory cycle and further downside, while bulls argue the competitive threat is years away and HBM demand remains strong.

Anthropics anticipated mega-IPO and reported prospectus disclosures are driving attention, as investors weigh rapid growth against heavy losses and enormous computing commitments. Traders are split over whether growth justifies the lofty expected valuation or whether spending and financing risks point to an AI bubble.

Reports that OpenAI may delay its IPO until 2027 are driving discussion, with traders debating whether market conditions and the companys substantial funding needs warrant waiting. Some see a future listing and AI demand as positives, while skeptics point to heavy losses, high valuation expectations, and competition from Anthropic and lower-cost models.

Bitcoins sharp, volatile swings and tests of key support are driving attention, with reports of leveraged long liquidations adding to the selling pressure. Traders are split between viewing pullbacks as buying opportunities and warning that weakness could deepen, while also debating Bitcoins sensitivity to interest rates and broader risk markets.

Barclays downgrade of NetApp to Equal Weight, citing elevated hardware valuations and no clear enterprise-AI spending inflection, is driving the pullback. Traders are split between dismissing the call as noise and arguing the rally has left storage stocks vulnerable to valuation pressure and growth normalization.